Science Explorer Interactive view Map

Circular RNAs in diseases

Circular RNAs in diseases is a research topic within Molecular Biology. Science Explorer counts 31k research works in it since 1961. 24.5% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the biogenesis, regulation, and diverse functions of circular RNAs, with a particular emphasis on their roles as microRNA sponges, potential cancer biomarkers, and their involvement in various cellular functions. The papers also explore the translation of circular RNAs, their association with exosomes, and their implications in disease.

  • Circular RNAs
  • Biogenesis
  • Regulation
  • MicroRNA Sponges
  • Cancer Biomarkers
  • Exosome
  • Translation
  • Splicing
  • Cellular Functions
  • Disease
Research works
31k
fractional, since 1961
In the world top 10%
7.5k
per year above
Top-10% rate
24.5%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+106%
the tick is no change

Which countries lead Circular RNAs in diseases research?

By volume, China and the United States publish the most (5.5k and 606 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 5.5k works
  2. 2 United States 606 works
  3. 3 Iran 383 works
  4. 4 India 284 works
  5. 5 Italy 165 works
  6. 6 Egypt 121 works
  7. 7 Germany 111 works
  8. 8 South Korea 109 works
  9. 9 Russia 104 works
  10. 10 Japan 97 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 73.7%United States: 8.1%Iran: 5.1%India: 3.8%6 others listed: 9.4%74%largest
China5,547 · 73.7%United States606 · 8.1%Iran383 · 5.1%India284 · 3.8%6 others listed707 · 9.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Circular RNAs in diseases research?

By volume in 2022–2025, Nanjing Medical University publishes the most Circular RNAs in diseases research, followed by Central South University and Sun Yat-sen University.

Who are the leading researchers in Circular RNAs in diseases?

The most-cited researchers publishing on Circular RNAs in diseases include Yi Zhang and Kai Wang.

  1. 1 Yi Zhang China 3.6k citations
  2. 2 Kai Wang China 3.1k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Circular RNAs in diseases research done?

The largest centres of Circular RNAs in diseases research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong and Hengyang.

Largest cities, 2022–2025

  1. 1 Beijing China 345 works
  2. 2 Shanghai China 339 works
  3. 3 Guangzhou China 338 works
  4. 4 Nanjing China 235 works
  5. 5 Changsha China 227 works
  6. 6 Wuhan China 222 works
  7. 7 Hangzhou China 175 works
  8. 8 Tehran Iran 157 works
  9. 9 Jinan China 141 works
  10. 10 Xi'an China 133 works

Where it is the local speciality

  1. NantongCN · 69.2 works18×
  2. HengyangCN · 47.5 works16×
← less than its size predictsmore →

Location quotient: how much more of its research is in Circular RNAs in diseases than the world average.

See Circular RNAs in diseases on the map

Where is the best place to study Circular RNAs in diseases?

Among universities, judged by research, Shahid Beheshti University of Medical Sciences, China Medical University and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.9%fractional works in this node (log) →share in the world top 10% →Shahid Beheshti University of Medical Sciences: 32, 25.2%China Medical University: 55, 21.9%Nanjing Medical University: 82, 18.9%Qingdao University: 38, 27.5%Guangzhou Medical University: 37, 18.5%Shanghai University of Traditional Chinese Medicine: 18, 29.1%Harbin Medical University: 47, 19.2%Xuzhou Medical College: 30, 21.1%Soochow University: 49, 21.7%Nantong University: 42, 15.9%Qingdao UniversityShahid Beheshti Univ…China Medical Univer…Nanjing Medical Univ…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Shahid Beheshti University of Medical SciencesIran 72.725.2%10.9×32 +1180.5%
2 China Medical UniversityChina 71.221.9%20.9×55 +182.9%
3 Nanjing Medical UniversityChina 70.518.9%19.9×82 +151.4%
4 Qingdao UniversityChina 70.127.5%8.3×38 +472.1%
5 Guangzhou Medical UniversityChina 68.218.5%16.9×37 +219.8%
6 Shanghai University of Traditional Chinese MedicineChina 68.029.1%11.1×18 +347.7%
7 Harbin Medical UniversityChina 67.819.2%28.7×47 +180.2%
8 Xuzhou Medical CollegeChina 66.121.1%17.2×30 +351.1%
9 Soochow UniversityChina 65.621.7%7.4×49 +196.9%
10 Nantong UniversityChina 65.615.9%14.6×42 +200.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Circular RNAs in diseases research growing?

Output in 2018–2022 was 106% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Circular RNAs in diseases.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.